Trials / Completed
CompletedNCT01278147
Cancer Fatigue Education Program
Development and Implementation of a Cancer Fatigue Education Program
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Institut de Cancérologie de la Loire · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the present project is to develop, implement and evaluate a pilot regional patient education program on the management of one of the main side effects of chemotherapy in cancer patients, that is fatigue. A carer (doctor or nurse) trained in educational techniques will be responsible for the patient. The carer will first identify modes of behavior and competences that the patient must acquire in order to optimize his/her management of fatigue ("educational diagnosis"). An education program, based on a contract of goals will be proposed after this diagnosis phase. The expected results are, in the short-term, a significant reduction in the mean level of fatigue in patients receiving chemotherapy who benefited from individual educational management. In the longer term, the aim is to evaluate the impact of this program on patient quality of life and use of healthcare structures in comparison with conventional management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | fatigue education program | the carer will help the patient develop competences on the following points: how to evaluate the severity of the fatigue; learn to recognize symptoms or prodromes showing associated difficulties (anxiety, fear, depression); how to improve control of fatigue by setting up suitable strategies (management of periods of activity and rest, physical and/or intellectual exercises, dietary program, complementary therapy); learn to ask for and accept the help of close relations or carers. |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2011-01-17
- Last updated
- 2011-01-17
Locations
7 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01278147. Inclusion in this directory is not an endorsement.